NCT00865319 - Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

December 31, 2010

Conditions

Non Small Cell Lung Cancer

Interventions

RADIATION

Radiolabeled (99Tc) EC-DG (ethylenedicysteine-deoxyglucose)

one injection of Technetium ethylenedicysteine-deoxyglucose to yield a target activity of 20mCi (range 20-30 mCi) to be given by slow IV push (over 3-5 minutes) 1mg of EC-DG to be injected

RADIATION

18 F fluorodeoxyglucose

single injection of 18F FDG (range 10-20mCi)

Trial Locations (6)

10461

Montefiore Medical Center, Department of Nuclear Medicine, The Bronx

21287

John Hopkins University, Baltimore

33143

Baptist Health South Florida, Coral Gables

55905

Mayo Clinic, Division of Nuclear Medicine, Rochester

62526

Decatur Memorial Hospital Department of Radiology, Decatur

V7L 2L7

Lions Gate Hospital, North Vancouver